Folgen
Carmen Almansa
Carmen Almansa
Chemistry Director, Esteve
Bestätigte E-Mail-Adresse bei esteve.com
Titel
Zitiert von
Zitiert von
Jahr
Synthesis and SAR of a New Series of COX-2-Selective Inhibitors:  Pyrazolo[1,5-a]pyrimidines
C Almansa, AF de Arriba, FL Cavalcanti, LA Gómez, A Miralles, M Merlos, ...
Journal of medicinal chemistry 44 (3), 350-361, 2001
2332001
Synthesis and structure− activity relationship of a new series of COX-2 selective inhibitors: 1, 5-diarylimidazoles
C Almansa, J Alfón, AF de Arriba, FL Cavalcanti, I Escamilla, LA Gómez, ...
Journal of medicinal chemistry 46 (16), 3463-3475, 2003
1782003
Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy …
JL Díaz, R Cuberes, J Berrocal, M Contijoch, U Christmann, A Fernández, ...
Journal of medicinal chemistry 55 (19), 8211-8224, 2012
1412012
Co-crystal of Tramadol Hydrochloride–Celecoxib (ctc): A Novel API–API Co-crystal for the Treatment of Pain
C Almansa, R Merce, N Tesson, J Farran, J Tomas, CR Plata-Salaman
Crystal Growth & Design 17 (4), 1884-1892, 2017
1362017
Synthesis and Structure−Activity Relationship of a New Series of Potent AT1 Selective Angiotensin II Receptor Antagonists:  5-(Biphenyl-4-ylmethyl)pyrazoles
C Almansa, LA Gómez, FL Cavalcanti, AF de Arriba, J García-Rafanell, ...
Journal of medicinal chemistry 40 (4), 547-558, 1997
1121997
Pyrazolopyridine derivates
CA Rosales, MV Bernadó
US Patent 7,468,376, 2008
99*2008
Pyrazolopyridine Derivates
CA Rosales, MV Bernadó
US Patent App. 12/511,469, 2009
922009
Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?
R Soliva, C Almansa, SG Kalko, FJ Luque, M Orozco
Journal of medicinal chemistry 46 (8), 1372-1382, 2003
792003
A potent and selective p38 inhibitor protects against bone damage in murine collagen‐induced arthritis: a comparison with neutralization of mouse TNFα
K Mihara, C Almansa, RL Smeets, E Loomans, J Dulos, PMF Vink, ...
British journal of pharmacology 154 (1), 153-164, 2008
672008
In vitro pharmacological characterization of a new selective angiotensin AT1 receptor antagonist, UR-7280
AF De Arriba, LA Gómez-Casajús, F Cavalcanti, C Almansa, ...
European journal of pharmacology 318 (2-3), 341-347, 1996
631996
Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl) cyanomethyl) piperazines as PAF antagonists
E Carceller, M Merlos, M Giral, C Almansa, J Bartroli, J Garcia-Rafanell, ...
Journal of medicinal chemistry 36 (20), 2984-2997, 1993
581993
Investigational sigma-1 receptor antagonists for the treatment of pain
JM Vela, M Merlos, C Almansa
Expert Opinion on Investigational Drugs 24 (7), 883-896, 2015
542015
Selective sigma-1 receptor antagonists for the treatment of pain
C Almansa, JM Vela
Future medicinal chemistry 6 (10), 1179-1199, 2014
542014
Diphenylpropionic acids as new AT1 selective angiotensin II antagonists
C Almansa, LA Gómez, FL Cavalcanti, AF de Arriba, R Rodríguez, ...
Journal of medicinal chemistry 39 (11), 2197-2206, 1996
521996
Synthesis and Biological Evaluation of a New Series of Hexahydro-2H-pyrano[3,2-c]quinolines as Novel Selective σ1 Receptor Ligands
JL Díaz, U Christmann, A Fernandez, M Luengo, M Bordas, R Enrech, ...
Journal of Medicinal Chemistry 56 (9), 3656-3665, 2013
492013
New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs
C Almansa, J Bartrolí, J Belloc, FL Cavalcanti, R Ferrando, LA Gómez, ...
Journal of medicinal chemistry 47 (22), 5579-5582, 2004
462004
[(3-Pyridylalkyl) piperidylidene] benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine
E Carceller, M Merlos, M Giral, D Balsa, C Almansa, J Bartroli, ...
Journal of medicinal chemistry 37 (17), 2697-2703, 1994
441994
8-chloro-11-[1-[(5-methyl-3-pyridyl) methyl]-4-piperidyliden]-6, 11-dihydro-5H-benzo [5, 6] cyclohepta [1,] pyridine
E Carceller, N Recasens, C Almansa, J Bartroli, M Merlos, M Giral, ...
US Patent 5,407,941, 1995
401995
Synthesis and Structure–Activity Relationship Study of a New Series of Selective σ1 Receptor Ligands for the Treatment of Pain: 4-Aminotriazoles
JL Díaz, U Christmann, A Fernandez, A Torrens, A Port, R Pascual, ...
Journal of medicinal chemistry 58 (5), 2441-2451, 2015
392015
A new pharmacophore model for the design of sigma-1 ligands validated on a large experimental dataset
R Pascual, C Almansa, C Plata-Salamán, JM Vela
Frontiers in Pharmacology 10, 452661, 2019
372019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20